by Melanie Costin | Aug 21, 2025 | New treatments
A combination of enfortumab vedotin (Padcev) and pembrolizumab (Keytruda) will be available on the NHS in England for people with advanced bladder cancer who are eligible to receive platinum chemotherapy. Until now, for decades, patients with advanced urothelial...
